Denileukin Diftitox in Combination with Rituximab for Previously Untreated Follicular B-cell Non-Hodgkin’s Lymphoma

Denileukin Diftitox in Combination with Rituximab for Previously Untreated Follicular B-cell Non-Hodgkin’s Lymphoma

Follicular lymphoma exhibits intratumoral infiltration by non-malignant T lymphocytes inluding CD4+CD25+ regulatory T (Treg) cells. We combined denileukin diftitox with rituximab in previously untreated, advanced-stage follicular lymphoma patients anticipating that denileukin diftitox would deplete...

Full description

Bibliographic Details
Main Authors: Ansell, Stephen M., Tang, Hui, Kurtin, Paul J., Koenig, Patricia A., Nowakowski, Grzegorz S., Nikcevich, Daniel A., Nelson, Garth D., Yang, Zhizhang, Grote, Deanna M., Ziesmer, Steven C., Silberstein, Peter T., Erlichman, Charles, Witzig, Thomas E.
Format: Online
Language:English
Published: 2011
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266999/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266999/

Similar Items